US Patent Issued to Bacainn Biotherapeutics on Sept. 23 for "Cyclosporine compositions and methods of use" (Massachusetts, Missouri Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,281, issued on Sept. 23, was assigned to Bacainn Biotherapeutics Ltd. (George Town, Cayman Islands).

"Cyclosporine compositions and methods of use" was invented by Chris Murphy (Upton, Mass.), Ronald Farquhar (Boston) and Roland E. Dolle (Eureka, Mo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are cyclosporine compounds and methods for use in the treatment or prevention of neutrophil-mediated inflammation, wherein the compounds inhibit the activity of MRP2 and FPRL."

The patent was filed on Aug. 19, 2022, under Application No. 17/891,351.

*For further information, including images, charts and tables, please visit: http://patft...